BioCentury | Apr 27, 2018
Company News

Freenome partners with Biognosys to develop cancer screen

...non-exclusively with Biognosys AG (Schlieren, Switzerland) to enhance Freenome’s AI-based genomics platform for detecting cell-free biomarkers. Biognosys...
...provide financial terms. Freenome Inc., South San Francisco, Calif. Biognosys AG, Schlieren, Switzerland Business: Diagnostic Jaime De Leon Biognosys AG Freenome...
BioCentury | Feb 13, 2018
Distillery Techniques

Assays and screens

...and identified 76 other metabolite-binding proteins that had no previously reported functions. Next steps by Biognosys AG...
...Unbiased, mass spectrometry-based method for protein-small molecule interactions LICENSING STATUS: Patent application filed; licensed to Biognosys AG...
...CONTACT: Paola Picotti, Swiss Federal Institute of Technology Zurich (ETHZ), Zurich, Switzerland email: picotti@imsb.biol.ethz.ch Jaime De Leon Biognosys AG Swiss...
BioCentury | Feb 8, 2018
Translation in Brief

Proteomic pathfinding

...Paola Picotti, a professor at ETHZ’s Institute of Molecular Systems Biology and a member of Biognosys AG’s...
...the authors to write that the method is unlikely to lead to false positive results. Biognosys...
...chemically, then you are dealing with a different compound.” Rinner added the method will allow Biognosys...
BioCentury | Jul 21, 2017
Financial News

Biognosys raises $5M in extended series C round

...Proteomics and supply/service company Biognosys AG (Schlieren, Switzerland) raised $5 million on July 12 in an extended...
...in an extended series C round from new and existing investors. Biognosys AG , Schlieren, Switzerland Alex Himes Biognosys AG...
BioCentury | Aug 4, 2016
Finance

2Q16 Public-Private Partnership Roundup

...of Switzerland. The other commercial partners are PHENOMIN project at the Mouse Clinical Institute , Biognosys AG...
...and Institutions Mentioned Alacris Theranostics GmbH, Berlin, Germany Bill & Melinda Gates Foundation, Seattle, Wash. Biognosys AG...
BioCentury | Nov 7, 2011
Financial News

Biognosys completes venture financing

Biognosys AG , Schlieren, Switzerland Business: Proteomics Date completed: 10/31/11 Type: Venture financing Raised: CHF2.7 million ($3.1 million) Investors: Syngenta; Redalpine Capital I; Cantonal Bank of Zurich; individual investors WIR Staff...
BioCentury | Aug 2, 1999
Company News

Biognosis U.S. Inc., Genomica Corp. deal

Biognosis obtained a non-exclusive license to Genomica’s Discovery Manager bioinformatic and pharmacogenomic software. Biognosis will use the system to study psychiatric phenotypes. Biognosis U.S. Inc. , Bethesda, Md. Genomica Corp. , Boulder, Co. Business: Enabling technology WIR...
Items per page:
1 - 7 of 7
BioCentury | Apr 27, 2018
Company News

Freenome partners with Biognosys to develop cancer screen

...non-exclusively with Biognosys AG (Schlieren, Switzerland) to enhance Freenome’s AI-based genomics platform for detecting cell-free biomarkers. Biognosys...
...provide financial terms. Freenome Inc., South San Francisco, Calif. Biognosys AG, Schlieren, Switzerland Business: Diagnostic Jaime De Leon Biognosys AG Freenome...
BioCentury | Feb 13, 2018
Distillery Techniques

Assays and screens

...and identified 76 other metabolite-binding proteins that had no previously reported functions. Next steps by Biognosys AG...
...Unbiased, mass spectrometry-based method for protein-small molecule interactions LICENSING STATUS: Patent application filed; licensed to Biognosys AG...
...CONTACT: Paola Picotti, Swiss Federal Institute of Technology Zurich (ETHZ), Zurich, Switzerland email: picotti@imsb.biol.ethz.ch Jaime De Leon Biognosys AG Swiss...
BioCentury | Feb 8, 2018
Translation in Brief

Proteomic pathfinding

...Paola Picotti, a professor at ETHZ’s Institute of Molecular Systems Biology and a member of Biognosys AG’s...
...the authors to write that the method is unlikely to lead to false positive results. Biognosys...
...chemically, then you are dealing with a different compound.” Rinner added the method will allow Biognosys...
BioCentury | Jul 21, 2017
Financial News

Biognosys raises $5M in extended series C round

...Proteomics and supply/service company Biognosys AG (Schlieren, Switzerland) raised $5 million on July 12 in an extended...
...in an extended series C round from new and existing investors. Biognosys AG , Schlieren, Switzerland Alex Himes Biognosys AG...
BioCentury | Aug 4, 2016
Finance

2Q16 Public-Private Partnership Roundup

...of Switzerland. The other commercial partners are PHENOMIN project at the Mouse Clinical Institute , Biognosys AG...
...and Institutions Mentioned Alacris Theranostics GmbH, Berlin, Germany Bill & Melinda Gates Foundation, Seattle, Wash. Biognosys AG...
BioCentury | Nov 7, 2011
Financial News

Biognosys completes venture financing

Biognosys AG , Schlieren, Switzerland Business: Proteomics Date completed: 10/31/11 Type: Venture financing Raised: CHF2.7 million ($3.1 million) Investors: Syngenta; Redalpine Capital I; Cantonal Bank of Zurich; individual investors WIR Staff...
BioCentury | Aug 2, 1999
Company News

Biognosis U.S. Inc., Genomica Corp. deal

Biognosis obtained a non-exclusive license to Genomica’s Discovery Manager bioinformatic and pharmacogenomic software. Biognosis will use the system to study psychiatric phenotypes. Biognosis U.S. Inc. , Bethesda, Md. Genomica Corp. , Boulder, Co. Business: Enabling technology WIR...
Items per page:
1 - 7 of 7